A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2001
11/01/2001	WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001	WO2001029189A3 Synthetic substrate for tissue formation
11/01/2001	WO2000034483A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	WO2000034442A3 Application of shear flow stress to smooth muscle cells for the production of implantable structures
11/01/2001	US20010036664 Graft-versus-host disease
11/01/2001	US20010036624 Liquid phase; capturing, recovering, removal
11/01/2001	US20010036454 Transfection of lung tissue
11/01/2001	US20010036453 Probiotic therapy for newborns
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	EP1144596A3 Application of shear flow stress to smooth muscle cells for the production of implantable structures
11/01/2001	CA2407424A1 Retinal pigment epithelial cell lines with extended life-span and their applications
11/01/2001	CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001	CA2407053A1 Pneumovirus ns proteins antagonize the interferon (ifn) response
11/01/2001	CA2405103A1 Chemical modification of mammalian urine and blood
10/2001
10/31/2001	EP1149917A2 Hepatitis B virus vectors for gene therapy
10/31/2001	EP1149916A2 Defective Adenoviruses and corresponding transcomplementant cell lines
10/31/2001	EP1149910A1 Pharmaceutical composition for treating papillomavirus tumours and infection
10/31/2001	EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001	EP1149586A1 Bidirectional modulation of immunity
10/31/2001	EP1149167A2 Viral vaccine
10/31/2001	EP1149159A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
10/31/2001	EP1148897A1 Methods and compositions for healing and repair of articular cartilage
10/31/2001	EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001	EP0869806B1 A pharmaceutical composition comprising plant worms and muirapuama
10/31/2001	EP0842279B1 Helper viruses for preparing recombinant viral vectors
10/31/2001	EP0641183B1 Coated transplant and method for making same
10/31/2001	EP0627918B1 New use of omega-3-fatty acids
10/31/2001	DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001	CN1320039A Reduction of oxidative stress factors
10/31/2001	CN1320032A Alginate capsules for use in the treatment of brain tumor
10/31/2001	CN1319431A Method for improving antitumor activity of amarogentin substance and its composition and evaluation method
10/31/2001	CN1319422A Medicine for treating psoriasis
10/31/2001	CN1319420A Medicine for treating asthma
10/31/2001	CN1319419A Medicine for clinical emergency treatment of cerebral hemorrhage
10/31/2001	CN1319417A Medicine for treating menopausal syndrome and preparation process thereof
10/31/2001	CN1319416A Liquid medicine for treating influenza virus and preparation process thereof
10/31/2001	CN1319415A Pill medicine for treating cardio-cerebro vascular diseases
10/31/2001	CN1319414A Medicine for treating hecrosis of femoral head
10/31/2001	CN1319403A Medicine for treating allergic purpura
10/31/2001	CN1319402A 眼部营养素 Eye Nutrients
10/31/2001	CN1319400A Epiderm specificity transfer factor
10/31/2001	CN1073855C 芦荟组合物 Aloe composition
10/31/2001	CN1073854C Tiandihua liquid for promoting hemopoiesis
10/31/2001	CN1073851C High efficiency ointment for curing beri-beri (tinea pedis)
10/31/2001	CN1073849C Chinese and western medicine capsule for curing psoriasis and leucodermia in sleep
10/31/2001	CN1073814C Bitersguash extract sugar-reducing milk power and its preparation process
10/30/2001	US6310195 Nucleic acid encoding a lectin-derived progenitor cell preservation factor
10/30/2001	US6310176 Antimicrobially active polypeptides
10/30/2001	US6310045 Compositions and methods for cancer immunotherapy
10/30/2001	US6309878 Glucose-inducible recombinant viral vector
10/30/2001	US6309645 A method of suppressing an immune response in a mammal.
10/30/2001	US6309634 Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)
10/30/2001	US6309524 Methods and apparatus for processing the surface of a microelectronic workpiece
10/30/2001	CA2220178C Dry preparations containing microbially produced oil
10/27/2001	CA2345444A1 Novel therapeutic processes and useful compositions therefor
10/25/2001	WO2001079518A2 Codon optimisation for expression in retrovirus packaging cells
10/25/2001	WO2001079502A2 Vectors for gene therapy
10/25/2001	WO2001079480A1 Albumin fusion proteins
10/25/2001	WO2001079469A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses
10/25/2001	WO2001079453A1 Cell culture method, cell cluster obtained by said methods and use thereof
10/25/2001	WO2001079452A2 Tolerance-inducing thy-marrow composite tissue construct and organ
10/25/2001	WO2001079445A2 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001	WO2001079444A2 Albumin fusion proteins
10/25/2001	WO2001079443A2 Albumin fusion proteins
10/25/2001	WO2001079442A2 Albumin fusion proteins
10/25/2001	WO2001079300A1 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor
10/25/2001	WO2001079286A2 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001	WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001	WO2001079273A2 Viruses comprising mutated ion channel protein
10/25/2001	WO2001079271A1 Albumin fusion proteins
10/25/2001	WO2001079260A1 Haemostatically active preparation containing vwf and method for the production thereof
10/25/2001	WO2001079258A1 Albumin fusion proteins
10/25/2001	WO2001078757A2 Reversible immortalization
10/25/2001	WO2001078754A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
10/25/2001	WO2001078753A2 Therapeutic uses for mesenchymal stromal cells
10/25/2001	WO2001078752A2 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs
10/25/2001	WO2001078685A1 A method of inducing or enhancing chondrogenesis with extracellular matrix containing bmp-4
10/25/2001	WO2001078674A1 A composition based on natural extracts useful in the prevention and treatment of cutaneous wrinkles
10/25/2001	WO2001078649A2 Pharmaceutical curative compound
10/25/2001	WO2001078533A2 Nutritional modules
10/25/2001	WO2001056596A8 Use of lysosomal acid lipase for treating atherosclerosis and related diseases
10/25/2001	WO2001049317A9 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/25/2001	WO2001026679A3 T-cells and molecules involved in immune regulation
10/25/2001	WO2001022976A3 Combination of a statin and ex-vivo treated blood for treating artheroclerosis
10/25/2001	WO2001022092A3 Method to identify compounds which modulate fra-1 expression fils
10/25/2001	WO2001021220A3 Bioprosthetic heart valves
10/25/2001	WO2000062788A9 Treatment of hypersensitivity reaction disorders
10/25/2001	US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001	US20010034323 Superoxygenating blood substitutes based on hemoglobin, nitric oxide and cyclic GMP generating compositions
10/25/2001	US20010034061 Culturing a population of mammalian cells capable of forming a solid tissue in a medium with oxygen level selected to enhance survival of the stem or progenitor cell type; subatmospheric oxygen; drug screening
10/25/2001	US20010033869 Fertilized egg which have been incubated
10/25/2001	US20010033844 Human Herpesvirus 6A and 6B transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis
10/25/2001	US20010033841 Atherosclerosis therapy
10/25/2001	US20010033840 Methods for inducing T cell tolerance to a tissue or organ graft
10/25/2001	US20010033838 Animal derived lipid
10/25/2001	US20010033837 Mixture containing stabilizer
10/25/2001	US20010033836 Transgenic autologous T-cell therapy in humans, and related compositions and kits
10/25/2001	US20010033835 Hematopoietic cell culture nutrient supplement
10/25/2001	US20010033834 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/25/2001	DE10019195A1 Gene complex for reversible cell immortalization, useful for expanding cells for cell replacement therapy of e.g. neurodegenerative disease, contains removable immortalizing gene

1 ... 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 ... 1259